Physician profile
John Barsanti
NPI 1447239405
$4,453.43
in general payments reported to CMS, 2019-2025
15 companies · $712 in 2025
The $712 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $586 · 2020: $135 · 2021: $732 · 2022: $588 · 2023: $897 · 2024: $804 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,413.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,782.04 | 2019-2025 | Wavewriter Alpha Prime 16, Coveredge 32, General - Pain Management |
| Medtronic USA, INC. | $128.64 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $117.86 | 2023-2025 | Relistor |
| Averitas Pharma INC. | $93.31 | 2024-2025 | Qutenza |
| Assertio Therapeutics, INC. | $81.46 | 2019-2020 | |
| Globus Medical, INC. | $55.13 | 2025 | Senza |
| Forte Bio-Pharma LLC | $39.23 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $35.55 | 2025 | |
| Pfizer INC. | $26.36 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.60 | 2019 | |
| Grt US Holding, INC. | $17.55 | 2022 | |
| Arbor Pharmaceuticals, INC. | $17.05 | 2021 | |
| Scilex Pharmaceuticals INC. | $15.55 | 2021 | |
| Avanos Medical | $13.34 | 2021 | |
| Sentynl Therapeutics, INC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Barsanti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.